12 results
Categories
Human Remove Human filter
Medicine type
Conditional approval Remove Conditional approval filter
Additional monitoring Remove Additional monitoring filter
Generic Remove Generic filter
Biosimilar Remove Biosimilar filter
Medicine
Orphan designations Remove Orphan designations filter
Summaries of opinion Remove Summaries of opinion filter
Application type
Post-authorisation Remove Post-authorisation filter
-
List item
Summary of opinion: Retsevmo
selpercatinib, opinion date: 22/04/2022, Positive, Last updated: 22/04/2022 -
List item
Summary of opinion: Crysvita
burosumab, opinion date: 23/06/2022, Positive, Last updated: 24/06/2022 -
List item
Summary of opinion: Ultomiris
ravulizumab, opinion date: 21/07/2022, Positive, Last updated: 22/07/2022 -
List item
Summary of opinion: Tecartus
Autologous peripheral blood T cells CD4 and CD8 selected and CD3 and CD28 activated transduced with retroviral vector expressing anti-CD19 CD28/CD3-zeta chimeric antigen receptor and cultured, opinion date: 21/07/2022, Positive, Last updated: 22/07/2022 -
List item
Summary of opinion: Retsevmo
selpercatinib, opinion date: 21/07/2022, Positive, Last updated: 22/07/2022 -
List item
Summary of opinion: Adtralza (new)
tralokinumab, opinion date: 15/09/2022, Positive, Last updated: 16/09/2022 -
List item
Summary of opinion: Skyrizi (new)
risankizumab, opinion date: 15/09/2022, Positive, Last updated: 16/09/2022 -
List item
Summary of opinion: Biktarvy (new)
bictegravir, emtricitabine, tenofovir alafenamide, opinion date: 15/09/2022, Positive, Last updated: 16/09/2022 -
List item
Summary of opinion: Brukinsa (new)
zanubrutinib, opinion date: 15/09/2022, Positive, Last updated: 16/09/2022 -
List item
Summary of opinion: Vaxneuvance (new)
pneumococcal polysaccharide conjugate vaccine (adsorbed), opinion date: 15/09/2022, Positive, Last updated: 16/09/2022 -
List item
Summary of opinion: Yescarta (new)
axicabtagene ciloleucel, opinion date: 15/09/2022, Positive, Last updated: 16/09/2022 -
List item
Summary of opinion: Imcivree
setmelanotide, opinion date: 21/07/2022, Positive, Last updated: 22/07/2022